uniQure NV (QURE)
24.69
-0.24
(-0.96%)
USD |
NASDAQ |
May 19, 16:00
24.57
-0.12
(-0.49%)
After-Hours: 20:00
uniQure EPS Diluted (Quarterly) : -0.8532 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| REGENXBIO, Inc. | -1.718 |
| ProQR Therapeutics NV | -0.1486 |
| argenx SE | -- |
| Pharming Group NV | -0.0746 |
| NewAmsterdam Pharma Co. NV | -0.398 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -53.54M |
| Revenue (Quarterly) | 3.562M |
| Total Expenses (Quarterly) | 57.10M |
| Enterprise Value | 1.516B |
| Gross Profit Margin (Quarterly) | 10.86% |
| Profit Margin (Quarterly) | -1.50K% |
| Earnings Yield | -14.23% |
| Normalized Earnings Yield | -14.04 |